Kinnate Biopharma (KNTE): Price and Financial Metrics

Kinnate Biopharma (KNTE): $2.65

0.01 (-0.38%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add KNTE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#127 of 364

in industry

KNTE Price/Volume Stats

Current price $2.65 52-week high $7.18
Prev. close $2.66 52-week low $1.04
Day low $2.64 Volume 2,812,200
Day high $2.68 Avg. volume 418,678
50-day MA $2.48 Dividend yield N/A
200-day MA $2.27 Market Cap 125.15M

KNTE Stock Price Chart Interactive Chart >


Kinnate Biopharma (KNTE) Company Bio


Kinnate Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA.


KNTE Latest News Stream


Event/Time News Detail
Loading, please wait...

KNTE Latest Social Stream


Loading social stream, please wait...

View Full KNTE Social Stream

KNTE Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 18.30%
3-year -86.82%
5-year N/A
YTD 11.81%
2023 -61.15%
2022 -65.58%
2021 -55.46%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!